文献速递类风湿关节炎系统性红斑狼疮其他结缔组织病

整合转录组与免疫表型数据揭示免疫介导疾病中B细胞致病动力学差异

Integration of transcriptome and immunophenotyping data highlights differences in the pathogenetic kinetics of B cells across immune-mediated disease.
PubMed 文献 · RMD Open · 2025-04-09

研究利用免疫表型与转录组学对235例六种免疫介导疾病患者进行分层,基于免疫表型分为两个聚类:聚类1富集分化B细胞,聚类2富集初始B细胞。聚类1中类风湿关节炎疾病活动度更高、系统性硬化症呼吸功能更低,而聚类2中系统性红斑狼疮疾病活动度更高;聚类2的年龄相关B细胞特征升高且疾病 flare 更频繁。

要点

  • 基于免疫表型可将免疫介导疾病患者分为富集分化B细胞的聚类1和富集初始B细胞的聚类2。
  • 聚类1与类风湿关节炎高疾病活动度及系统性硬化症低呼吸功能相关,聚类2与系统性红斑狼疮高疾病活动度相关。
  • 聚类2具有升高的年龄相关B细胞特征且 flare 更频繁,提示初始B细胞比例增加伴该特征与不良预后相关。

核心结论

  • 基于免疫表型的聚类和基于转录组的状态揭示了B细胞在数量和质量上的差异,评估初始B细胞的数量和质量可能对预测免疫介导疾病预后至关重要。

研究设计与样本

  • 研究对来自235例六种免疫介导疾病患者的23个免疫细胞亚群进行流式细胞术和转录组学分析,使用数据库ImmuNexUT,并根据免疫表型数据对患者进行分层。

主要发现

  • 免疫介导疾病患者根据免疫表型被分为两个聚类:聚类1富集未转换记忆B细胞、转换记忆B细胞、双阴性B细胞和浆母细胞等分化B细胞,聚类2富集初始B细胞。
  • 聚类1中观察到类风湿关节炎疾病活动度更高和系统性硬化症呼吸功能降低,而聚类2中系统性红斑狼疮疾病活动度更高。
  • 未转换记忆B细胞中检测到大量差异表达基因;聚类1与未转换记忆B细胞的糖基化过程及髓系细胞来源的B细胞激活因子信号在B细胞中升高相关,聚类2则显示未转换记忆B细胞中B细胞受体信号更高。
  • 聚类2具有升高的年龄相关B细胞特征,且 flare 更频繁,提示具有该特征的初始B细胞比例增加与不良预后相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To elucidate crucial immune cell subsets and associated immunological pathways by stratifying patients with immune-mediated diseases (IMDs) using immunophenotyping and transcriptomic approaches. METHODS: We conducted flow cytometric and transcriptomic analyses in 23 immune cell subsets derived from 235 patients with six IMDs, using our database, utilizing our database, ImmuNexUT. Patients were stratified based on immunophenotyping data. Subsequently, we examined clinical and transcriptomic differences among these stratified clusters. RESULTS: Patients with IMDs were stratified into two clusters based on their immunophenotypes. Cluster 1 was enriched with differentiated B cells, including unswitched memory B cells (USM B), switched memory B cells, double-negative B cells and plasmablasts, while cluster 2 was enriched with naïve B cells. Higher disease activity in rheumatoid arthritis and decreased respiratory functions in systemic sclerosis were observed in cluster 1, whereas the disease activity of systemic lupus erythematosus was higher in cluster 2. Numerous differentially expressed genes were detected in USM B. Cluster 1 was associated with glycosylation processes in USM B and elevated B cell-activating factor signalling from myeloid cells in B cells, while cluster 2 exhibited higher B-cell receptor signalling in USM B. Patients in cluster 2, which had an elevated age-associated B-cell signature, exhibited more frequent flares, suggesting that an increased proportion of naïve B cells with this signature is associated with poor prognosis. CONCLUSION: Immunophenotyping-based clusters and transcriptome-based states revealed quantitative and qualitative differences in B cells. To predict IMD prognosis, assessing both the quantity and quality of naïve B cells may be crucial.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Izuka S, Komai T, Itamiya T, et al. Integration of transcriptome and immunophenotyping data highlights differences in the pathogenetic kinetics of B cells across immune-mediated disease. RMD Open. 2025. PMID: 40210259. doi:10.1136/rmdopen-2024-005310

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。